139 related articles for article (PubMed ID: 33961088)
1. [Preconditioning of vascularized high-risk eyes using fine-needle diathermy and cross-linking].
Matthaei M; Hos D; Bock F; Le VNH; Hou Y; Schaub F; Siebelmann S; Zhang W; Roters S; Bachmann BO; Cursiefen C
Ophthalmologe; 2021 Jun; 118(6):553-560. PubMed ID: 33961088
[TBL] [Abstract][Full Text] [Related]
2. Cutting Edge: Novel Treatment Options Targeting Corneal Neovascularization to Improve High-Risk Corneal Graft Survival.
Cursiefen C; Hos D
Cornea; 2021 Dec; 40(12):1512-1518. PubMed ID: 34116541
[TBL] [Abstract][Full Text] [Related]
3. Risk of Corneal Graft Rejection After High-risk Keratoplasty Following Fine-needle Vessel Coagulation of Corneal Neovascularization Combined With Bevacizumab: A Pilot Study.
Hos D; Le VNH; Hellmich M; Siebelmann S; Roters S; Bachmann BO; Cursiefen C
Transplant Direct; 2019 May; 5(5):e452. PubMed ID: 31165087
[TBL] [Abstract][Full Text] [Related]
4. UV light-mediated corneal crosslinking as (lymph)angioregressive pretreatment to promote graft survival after subsequent high-risk corneal transplantation (CrossCornealVision): protocol for a multicenter, randomized controlled trial.
Wiedemann J; Hos D; Limburg E; Zettelmeyer U; Schiller P; Franklin J; Bachmann B; Böhringer D; Dietrich-Ntoukas T; Fuchsluger TA; Geerling G; Lang SJ; Mayer WJ; Priglinger S; Reinhard T; Seitz B; Cursiefen C
Trials; 2024 Mar; 25(1):169. PubMed ID: 38448965
[TBL] [Abstract][Full Text] [Related]
5. [Standardized semiquantitative analysis of corneal neovascularization using projected corneal photographs--pilot study after perforating corneal keratoplasty before immune reaction].
Cursiefen C; Wenkel H; Martus P; Langenbucher A; Seitz B; Küchle M
Klin Monbl Augenheilkd; 2001 Jul; 218(7):484-91. PubMed ID: 11512248
[TBL] [Abstract][Full Text] [Related]
6. Fine needle diathermy - a choice for managing corneal vascularization.
Thatte S
Nepal J Ophthalmol; 2011; 3(1):23-6. PubMed ID: 21505542
[TBL] [Abstract][Full Text] [Related]
7. Fine needle diathermy occlusion of corneal vessels.
Faraj LA; Elalfy MS; Said DG; Dua HS
Br J Ophthalmol; 2014 Sep; 98(9):1287-90. PubMed ID: 24782468
[TBL] [Abstract][Full Text] [Related]
8. Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis.
Bachmann B; Taylor RS; Cursiefen C
Ophthalmology; 2010 Jul; 117(7):1300-5.e7. PubMed ID: 20605214
[TBL] [Abstract][Full Text] [Related]
9. Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs.
Koenig Y; Bock F; Kruse FE; Stock K; Cursiefen C
Cornea; 2012 Aug; 31(8):887-92. PubMed ID: 22362005
[TBL] [Abstract][Full Text] [Related]
10. [Descemet membrane endothelial keratoplasty (DMEK) for graft failure after penetrating keratoplasty and in vascularized high-risk eyes].
Hos D; Schlereth S; Schrittenlocher S; Hayashi T; Bock F; Matthaei M; Bachmann BO; Cursiefen C
Ophthalmologe; 2021 Jun; 118(6):536-543. PubMed ID: 33860823
[TBL] [Abstract][Full Text] [Related]
11. [Sustained rapamycin drug delivery system in prevention of high risk corneal allograft rejection and neovascularization in rabbits].
Gao H; Shi WY; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):6-11. PubMed ID: 16638273
[TBL] [Abstract][Full Text] [Related]
12. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.
Shi W; Gao H; Xie L; Wang S
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3339-44. PubMed ID: 16877400
[TBL] [Abstract][Full Text] [Related]
13. Fine needle diathermy occlusion of corneal vessels.
Pillai CT; Dua HS; Hossain P
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2148-53. PubMed ID: 10892856
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic Trafficking in the Eye: Modulation of Lymphatic Trafficking to Promote Corneal Transplant Survival.
Hou Y; Bock F; Hos D; Cursiefen C
Cells; 2021 Jul; 10(7):. PubMed ID: 34359831
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin inhibits corneal allograft rejection and neovascularization.
Olsen TW; Benegas NM; Joplin AC; Evangelista T; Mindrup EA; Holland EJ
Arch Ophthalmol; 1994 Nov; 112(11):1471-5. PubMed ID: 7980138
[TBL] [Abstract][Full Text] [Related]
16. Long-term topical bevacizumab for prevention of corneal graft rejections.
Kuo HH; Shen EP
Eur J Ophthalmol; 2021 Nov; 31(6):NP48-NP52. PubMed ID: 32613854
[TBL] [Abstract][Full Text] [Related]
17. Subconjunctival and/or intrastromal bevacizumab injections as preconditioning therapy to promote corneal graft survival.
Fasciani R; Mosca L; Giannico MI; Ambrogio SA; Balestrazzi E
Int Ophthalmol; 2015 Apr; 35(2):221-7. PubMed ID: 24715230
[TBL] [Abstract][Full Text] [Related]
18. Corneal transduction to inhibit angiogenesis and graft failure.
Murthy RC; McFarland TJ; Yoken J; Chen S; Barone C; Burke D; Zhang Y; Appukuttan B; Stout JT
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1837-42. PubMed ID: 12714613
[TBL] [Abstract][Full Text] [Related]
19. [Anti(lymph)angiogenic preconditioning prior to keratoplasty].
Cursiefen C; Regenfuss B; Hos D; Bucher F; Steven P; Heindl LM; Bock F
Klin Monbl Augenheilkd; 2013 May; 230(5):500-4. PubMed ID: 23695846
[TBL] [Abstract][Full Text] [Related]
20. Graft rejection and failure following endothelial keratoplasty (DSAEK) and penetrating keratoplasty for secondary endothelial failure.
Pedersen IB; Ivarsen A; Hjortdal J
Acta Ophthalmol; 2015 Mar; 93(2):172-7. PubMed ID: 25130326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
